Company Directory / research

NiKang Therapeutics logo

PrivateFor profitresearchWilmington, United States

NiKang Therapeutics

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Founded
2017
9 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$260M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

201719002026

9 years old.

Reach

Website ranked #3,929,725 in the world for traffic, about 3k visits a month.

What it does

BiotechnologyHealth CareMedicalOncology

Funding, as listed

$260M currency not stated

  • Rounds3
  • LatestSeries c, May 2021
  • Investors24, 5 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersYan Lou, Zhenhai Gao

Every detail we hold

Everything the source datasets list about NiKang Therapeutics, field by field. Contact details are held but never shown.

The company

Name
NiKang Therapeutics
Type
For profit
Status
Private
Founded
2017
Founders
Yan Lou, Zhenhai Gao
Industry
research
Categories
Biotechnology, Health Care, Medical, Oncology

Where

City
Wilmington
Country
United States
Markets
Greater Philadelphia Area, East Coast, Southern US

Size and reach

Staff band
11-50
Web traffic rank
#3,929,725
Monthly web visits
2,850

Funding, as listed

Total
260,000,000 (currency not stated)
Rounds
3
Latest round
Series c
Latest round date
May 2021
Investors
24
Lead investors
5
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

NiKang Therapeutics may be growing as evidenced by a new collaboration agreement with Roche, a Swiss pharmaceutical giant, to study a deadly liver cancer. This partnership could indicate an expansion of NiKang's research and development capabilities and potential revenue streams. Additionally, the company's presence in news sources suggests an active role in the biotechnology and oncology sectors, which may contribute to its visibility and growth within the industry.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.